Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anatomical, histomorphological and molecular classification of cholangiocarcinoma
Timothy J. Kendall, Joanne Verheij, Eugenio Gaudio, et al.
Liver International (2019) Vol. 39, Iss. S1, pp. 7-18
Open Access | Times Cited: 267

Showing 1-25 of 267 citing articles:

Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesús M. Bañales, José J.G. Marı́n, Ángela Lamarca, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 9, pp. 557-588
Open Access | Times Cited: 1722
Biliary tract cancer
Juan W. Valle, Robin Katie Kelley, Bruno Nervi, et al.
The Lancet (2021) Vol. 397, Iss. 10272, pp. 428-444
Closed Access | Times Cited: 670
Cholangiocarcinoma
Paul J. Brindley, Melinda Bachini, Sumera I. Ilyas, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 503
Systemic therapies for intrahepatic cholangiocarcinoma
Robin Kate Kelley, John Bridgewater, Gregory J. Gores, et al.
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 353-363
Open Access | Times Cited: 321
Cholangiocarcinoma
Samantha Sarcognato, Diana Sacchi, Matteo Fassan, et al.
Pathologica (2021) Vol. 113, Iss. 3, pp. 158-169
Open Access | Times Cited: 125
Single-cell transcriptomic analysis suggests two molecularly distinct subtypes of intrahepatic cholangiocarcinoma
Guohe Song, Yang Shi, Meng Lu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 91
Friend or foe? The elusive role of hepatic stellate cells in liver cancer
Bruno Cogliati, Chittampalli Yashaswini, Shuang Wang, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 10, pp. 647-661
Open Access | Times Cited: 63
Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021
Pojsakorn Danpanichkul, Kanokphong Suparan, Primrose Tothanarungroj, et al.
Gut (2024) Vol. 74, Iss. 1, pp. 26-34
Closed Access | Times Cited: 29
Digestive cancers: mechanisms, therapeutics and management
Tianzuo Zhan, Johannes Betge, Nadine Schulte, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Pathogenesis of Cholangiocarcinoma
Pedro M. Rodrigues, Paula Olaizola, Nuno A. Paiva, et al.
Annual Review of Pathology Mechanisms of Disease (2020) Vol. 16, Iss. 1, pp. 433-463
Open Access | Times Cited: 108
Therapy of Primary Liver Cancer
Mei Feng, Yisheng Pan, Ruirui Kong, et al.
The Innovation (2020) Vol. 1, Iss. 2, pp. 100032-100032
Open Access | Times Cited: 78
Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and Programmed Death 1/Programmed Death‐Ligand 1 Blockade Responses
Jihoon G. Yoon, Min Hwan Kim, Mi Jang, et al.
Hepatology (2021) Vol. 74, Iss. 4, pp. 1914-1931
Closed Access | Times Cited: 68
Cell of origin in biliary tract cancers and clinical implications
Agrin Moeini, Philipp K. Haber, Daniela Sia
JHEP Reports (2021) Vol. 3, Iss. 2, pp. 100226-100226
Open Access | Times Cited: 59
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions
Rocı́o I.R. Macı́as, Vincenzo Cardinale, Timothy J. Kendall, et al.
Gut (2022), pp. gutjnl-327099
Open Access | Times Cited: 52
Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing
Olaf Neumann, Timothy C. Burn, Michael Allgäuer, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 8, pp. 1540-1549
Open Access | Times Cited: 42
Biology of IDH mutant cholangiocarcinoma
Meng‐Ju Wu, Lei Shi, Joshua Merritt, et al.
Hepatology (2022) Vol. 75, Iss. 5, pp. 1322-1337
Closed Access | Times Cited: 41
Plasmon‐Enhanced Single Extracellular Vesicle Analysis for Cholangiocarcinoma Diagnosis
Mi Ho Jeong, Taehwang Son, Yoo Keung Tae, et al.
Advanced Science (2023) Vol. 10, Iss. 8
Open Access | Times Cited: 29
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
Diego F. Calvisi, Luke Boulter, Javier Vaquero, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 7, pp. 462-480
Open Access | Times Cited: 23
Mast cells: key players in digestive system tumors and their interactions with immune cells
Feihong Shu, Jie Yu, Youjia Liu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Potential Influence of Antifungal-drug Resistant Pathogens in Patients with Cholangiocarcinoma and the Application of Nanoparticle Mechanisms as Novel Antifungal and Anticancer Agents
Conrad Chibunna Achilonu, Tsepo Ramatla, Maleke Maleke, et al.
Current Clinical Microbiology Reports (2025) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Distinct clinical and prognostic implication of IDH1/2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic cholangiocarcinoma
Bingqi Ma, Huijuan Meng, Ye Tian, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 62
Tumor-associated macrophages in cholangiocarcinoma: complex interplay and potential therapeutic target
Menghua Zhou, Chaoqun Wang, Shounan Lu, et al.
EBioMedicine (2021) Vol. 67, pp. 103375-103375
Open Access | Times Cited: 53
A Predictive Model Based on the Gut Microbiota Improves the Diagnostic Effect in Patients With Cholangiocarcinoma
Tan Zhang, Sina Zhang, Jin Chen, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 48
Liquid biopsy in cholangiocarcinoma: Current status and future perspectives
Gianluca Rompianesi, Marcello Di Martino, Alex Gordon‐Weeks, et al.
World Journal of Gastrointestinal Oncology (2021) Vol. 13, Iss. 5, pp. 332-350
Open Access | Times Cited: 44
The new insight of treatment in Cholangiocarcinoma
Yuhang Li, Yinghui Song, Sulai Liu
Journal of Cancer (2022) Vol. 13, Iss. 2, pp. 450-464
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top